Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsDENTALGeneric

APHTHASOL

AMLEXANOX

Standard Dose
5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview APHTHASOL is listed in Drugs@FDA under application 020511 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLEXANOX Form and strength PASTE;DENTAL - 5% Sponsor ULURU Submission history Latest submission status date: 2002-06-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview APHTHASOL is listed in Drugs@FDA under application 020511 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMLEXANOX Form and strength PASTE;DENTAL - 5% Sponsor ULURU Submission history Latest submission status date: 2002-06-11 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
APHTHASOL (AMLEXANOX) | Drug Monograph | MedicHelpline